. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 2004 Aug 5;43(3):321-32. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. Important and interesting work, but one question. What kind of mice would be a relevant control for 3XTg mice? Sarcastically speaking, transgenic expression of BSA may accelerate tau pathology in tau transgenic mice. Thus, there remains the danger that using 3XTg mice for drug screening might produce artifacts.